Jim Simons acquired 1.41 Million Novavax shares worth $8.41 Million. That's 0.01% of their equity portfolio (1018th largest holding). The first Novavax trade was made in Q3 2020. Since then Jim Simons bought shares six more times and sold shares on five occasions. The investor's estimated purchase price is $16 Million, resulting in a loss of 48%.